Fast Five Quiz: Do You Know Current Guidelines for Lipid Management?

Yasmine S. Ali, MD, FACC, FACP, MSCI; Mary Ellen T. Sweeney, MD


March 25, 2016

Current guidelines identify the following groups as deriving the most benefit from statin therapy:

  • Individuals who have established clinical ASCVD, which is defined as proven coronary heart disease (CHD), stroke, or peripheral arterial disease of atherosclerotic origin: High-intensity or moderate-intensity statin therapy should be initiated, depending on age.

  • Individuals with LDL-C levels of 190 mg/dL or higher who are likely to have familial hypercholesterolemia: High-intensity statin therapy should be initiated unless they are not candidates, in which case moderate-intensity statin therapy should be started.

  • Individuals age 40-75 years with diabetes mellitus (type 1 or 2) and LDL-C levels of 70-189 mg/dL: Moderate-intensity statin therapy is indicated, unless the estimated 10-year ASCVD risk is 7.5% or higher.

  • Individuals who do not have ASCVD or diabetes mellitus, who are age 40-75 years, and who have an estimated 10-year ASCVD risk of 7.5% or higher: Moderate-intensity to high-intensity statin therapy is indicated.

For more on statin use, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.